FDA Approves First Generic Ketoprofen For Use In Horses Sponsored by:
The FDA has approved KetoMed, the first generic ketoprofen for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses.
Musculoskeletal disorders are prevalent in aging horses and can cause pain, weakness, stiffness and decreased range of motion in the animals joints. Osteoarthritis and chronic laminitis are among the most common musculoskeletal disorders in horses and can greatly impact a horse s performance and quality of life.
KetoMed contains the same active ingredient (ketoprofen) in the same concentration and dosage form as the approved brand name drug product, Ketofen, which was first approved on September 26, 1990. In addition, the FDA determined that KetoMed contains no inactive ingredients that may significantly affect the bioavailability of the active ingredient.